Cost Transparency Rx

Register for Rx Purchaser Notifications

Register to receive 60-day advance notice of a specified increase in the wholesale acquisition cost of a prescription drug from prescription drug manufacturers.

Current List of Registered Rx Purchasers

Download the list of registered prescription drug purchasers for the purpose of 60-day advance notice of a specified increase in the wholesale acquisition cost of a prescription drug, as required by Senate Bill 17. This list will be updated weekly or as needed to include all current registrants.

SB 17 Overview

Senate Bill (SB) 17 (Chapter 603, Statutes of 2017)

The implementation plan outlined below describes the provisions of SB 17 involving OSHPD. There are also provisions that will be implemented by the Department of Managed Health Care and the California Department of Insurance.

Read Senate Bill 17


Beginning January 1, 2018, SB 17 requires OSHPD to make available a registry of public and private purchasers for purposes of the 60-day advance notice requirement for specified increases in the wholesale acquisition cost of a prescription drug. Public and private purchasers may register with OSHPD beginning December 1, 2017 on this website.

Beginning January 1, 2019, drug manufacturers must notify OSHPD within three days of introducing a new drug at a wholesale acquisition cost that exceeds the specified threshold. Within 30 days of this notification, manufacturers must submit additional information to OSHPD. OSHPD will publish this information on its website quarterly.

Beginning after January 1, 2019, drug manufacturers are required to submit to OSHPD information on the rationale for cost increases for existing drugs that fall under the reporting requirement. OSHPD will collect this information beginning April 2019 and publish on its website within 60 days of receipt from each manufacturer on a quarterly basis.

Read the Full November 2017 Implementation Plan


Upcoming Activities

Projected Time Period
OSHPD Activities
July 2018 Open rulemaking period and conduct public forum for comment.
September - December 2018 Release preliminary information reporting requirements and information collection format to drug manufacturers and share with stakeholders.
January 1, 2019 Formally adopt regulations.
January 2019 Begin collecting information related to new prescription drugs from drug manufacturers. OSHPD to publish this information quarterly on its website beginning Spring 2019.
April 2019 Begin collecting first quarter 2019 prescription drug cost increase information for existing drugs from drug manufacturers.
By June 2019 Publish first quarter 2019 drug cost increase information for existing drugs on OSHPD website.

Workshops

Event Date Location Materials
Data User Workshop March 15th, 2018
1-5pm
2020 West El Camino Avenue
Sacramento, CA 95833
Agenda
Presentation
User Story Template
Summary
Data Submitter Workshop April 11th, 2018
1-5pm
2020 West El Camino Avenue
Sacramento, CA 95833
Agenda
Presentation
Summary

OSHPD conducted a workshop March 15, 2018 focused on eliciting feedback from data users on the information OSHPD will publish per the provisions of SB 17. OSHPD conducted a second workshop on April 11, 2018 focused on eliciting feedback from data submitters on the requirements for data that OSHPD will collect per the provisions of Senate Bill 17. The materials from both these workshops are available on this webpage.


FAQs


This page was last updated on Tuesday, May 2, 2018.

Contact CTRx

Email Cost Transparency Rx Email Cost Transparency Rx

Sign up for CTRx Informational Announcements Sign up for CTRx Informational Announcements